Three Months Ended July 31, | Six Months Ended July 31, | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
(unaudited, in thousands) | ||||||||||||||||
Stock-based compensation: | ||||||||||||||||
Cost of revenue | $ | 885 | $ | 362 | $ | 1,826 | $ | 711 | ||||||||
Research and development | 18,550 | 17,883 | 36,911 | 35,034 | ||||||||||||
Selling, general and administrative | 8,687 | 8,664 | 16,650 | 18,205 | ||||||||||||
Total stock-based compensation | $ | 28,122 | $ | 26,909 | $ | 55,387 | $ | 53,950 |
Ambarella, Inc. Announces Second Quarter Fiscal Year 2024 Financial Results
| | More IC News |
|
The following tables present details of stock-based compensation and acquisition-related costs included in each functional line item in the condensed consolidated statements of operations above:
RELATED NEWS